Atrial Fibrillation Surgery Market - Top Companies and Manufacturers

Companies Dominating the Atrial Fibrillation Surgery Landscape

Abbott Laboratories.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
AtriCure, Inc.,

Biosense Webster, Inc.,
Boehringer Ingelheim GmbH
Boston Scientific Corporation
Bristol-Myers Squibb Corporation
CardioFocus, Inc.,
Endoscopic Technologies, Inc.,
Sanofi Aventis,
Johnson and Johnson Ltd.,

Browse Key Market Insights with Data Illustration:

Atrial Fibrillation Surgery Market Size & Share, Growth Analysis 2037

In the News

physIQ, which uses wearable biosensor data to generate personalized, clinically valid, actionable insights announced a strategic collaboration with InCarda Therapeutics, Inc., and a privately-held, clinical-stage biopharmaceutical company developed inhaled therapies for cardiovascular diseases. In patients with atrial fibrillation, this collaboration is intended to speed up the Phase III study.
Abbott reported positive results from the PERSISTEND study of its TactiCath Contact Force Ablation Catheter, Sensor Enabled, in May 2022. (TactiCath SE) for persistent atrial fibrillation (AFib), the most common arrhythmia

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of atrial fibrillation surgery is assessed at USD 4.67 billion.

The atrial fibrillation surgery market size was valued at USD 4.1 billion in 2024 and is expected to reach USD 33 billion by 2037, registering around 17.4% CAGR during the forecast period i.e., between 2025-2037. Increasing technological advancements, new product launches, rise in people with atrial fibrillation conditions will drive the market growth.

Asia Pacific industry is expected to hold largest revenue share of 32% by 2037, impelled by increasing popularity of the use of minimum-invasive procedures in the region.

The major players in the market include Abbott Laboratories., AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd.

Atrial Fibrillation Surgery Market - Top Companies and Manufacturers

Companies Dominating the Atrial Fibrillation Surgery Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the atrial fibrillation surgery market worth?

Why is the demand for atrial fibrillation surgery growing?

Which region dominated the majority of atrial fibrillation surgery industry share?

Who are the top atrial fibrillation surgery companies?